Clinical Trials Browser

Interventional × Cabergoline × Endocrine × Clear all

Pituitary Neoplasms

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Phase 3 Active not recruiting

60 enrolled

Endocrine

Adenoma, Pituitary Neoplasms

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT01915303 2020-09-18

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Phase 2 Terminated

68 enrolled 25 charts

Endocrine

Adrenocortical Hyperfunction, Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT03457389 2020-03-18

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Phase NA Unknown

68 enrolled

Endocrine

Pituitary Neoplasms, Recurrence, Prolactinoma

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

Phase 3 Completed

140 enrolled

Endocrine

Pituitary Neoplasms

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Phase 4 Completed

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Clinical Trials

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Cabergoline in Nonfunctioning Pituitary Adenomas

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor